Literature DB >> 18979533

Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin.

Rahul P Patel1, Christian Narkowicz, Glenn A Jacobson.   

Abstract

The objective of this study was to investigate the effects of heating on the chemistry, physical properties and antifactor Xa activity of enoxaparin. Samples of enoxaparin heated at 70 degrees C lost 27% of their initial AFXa activity after 8 h, then activity increased to 94% of the initial activity over the next 4 h. Activity then decreased to 84% of control after 48 h and further to 80% of control over 22 days. The initial activity loss correlated with desulfation as demonstrated by sulfate and amine analysis. Fragmentation of oligosaccharides occurred, as demonstrated by reducing capacity and capillary electrophoresis analysis. Individual enoxaparin fractions obtained by high performance size exclusion chromatography were analysed. Early eluting fractions, containing aggregated oligosaccharides, increased in concentration following heating. Up to 65% of sulfate was lost from some fractions, containing hexa- and octa-saccharides, after 8 h, corresponding with decreased activity. Low mass oligosaccharide fractions increased in concentration and had increased activity between 8 and 12 h. Reversed-phase ion-interaction HPLC analysis supported these findings. Deca-, dodeca- and tetradeca-saccharides were resistant to thermal degradation. Desulfation, fragmentation and aggregation occur during the heating of enoxaparin and result in the initial rapid loss, recovery and subsequent gradual loss of activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18979533     DOI: 10.1002/jps.21556

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Impact of autoclave sterilization on the activity and structure of formulated heparin.

Authors:  Julie M Beaudet; Amanda Weyers; Kemal Solakyildirim; Bo Yang; Majde Takieddin; Shaker Mousa; Fuming Zhang; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2011-03-17       Impact factor: 3.534

2.  Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.

Authors:  Madhur D Shastri; Niall Stewart; James Horne; Syed Tabish R Zaidi; Sukhwinder Singh Sohal; Gregory M Peterson; Heinrich Korner; Nuri Gueven; Rahul P Patel
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

3.  In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin.

Authors:  Madhur D Shastri; Niall Stewart; James Horne; Gregory M Peterson; Nuri Gueven; Sukhwinder S Sohal; Rahul P Patel
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

4.  Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.

Authors:  Madhur D Shastri; Niall Stewart; Mathew Eapen; Gregory M Peterson; Syed Tabish R Zaidi; Nuri Gueven; Sukhwinder Singh Sohal; Rahul P Patel
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

Review 5.  Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.

Authors:  Rahul P Patel; Madhur D Shastri; Long Chiau Ming; Syed Tabish R Zaidi; Gregory M Peterson
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

Review 6.  Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.

Authors:  Fahad Akhtar; Xinyu Wan; Gang Wu; Samuel Kesse; Shaoda Wang; Shuying He
Journal:  Molecules       Date:  2018-07-18       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.